Trials / Completed
CompletedNCT00447629
Study Evaluating Single Doses of PPM-204 on the Electrical Pathways of the Heart
A Randomized, Double-Blind, Placebo- and Moxifloxacin (Open-Label)- Controlled, 4-Period Crossover Study of the Effects of Single Oral Doses of PPM 204 on Cardiac Repolarization in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A study evaluating the safety of a high and low dose of PPM-204 on the electrical pathways of the heart.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PPM-204 |
Timeline
- Start date
- 2007-01-01
- Completion
- 2007-03-01
- First posted
- 2007-03-15
- Last updated
- 2007-12-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00447629. Inclusion in this directory is not an endorsement.